Position in QTTB
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$769,024
-$6,310,573 QoQ
Shares Held
60,363
-94.5% QoQ
Ownership
0.203%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#26
of 71 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in QTTB Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Carlyle Group Inc. holds $44,066,764 across 6 Biotechnology names. QTTB ranks #5 (1.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PHAT |
Phathom Pharmaceuticals, Inc.
|
3,496,808 | $37,940,366 | |
| 2 | SPRB |
Spruce Biosciences, Inc.
|
38,620 | $2,085,480 | |
| 3 | ACET |
Adicet Bio, Inc.
|
184,295 | $1,592,308 | |
| 4 | OKUR |
OnKure Therapeutics, Inc.
|
269,895 | $1,230,721 | |
| 5 | QTTB |
Q32 Bio Inc.
This page
|
60,363 | $769,024 | |
| 6 | JSPR |
Jasper Therapeutics, Inc.
|
1,066,189 | $448,865 |
All Filings in QTTB
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $769,024 | 60,363 | Shares | Defined | 2026-08-07 | |
| 2026-03-31 | $7,079,597 | 1,102,741 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $3,661,100 | 1,102,741 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $2,183,427 | 1,102,741 | Shares | Defined | 2025-11-07 | |
| 2025-06-30 | $1,643,084 | 1,102,741 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $1,819,522 | 1,102,741 | Shares | Defined | 2025-05-09 | |
| 2024-12-31 | $3,793,429 | 1,102,741 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $49,204,303 | 1,102,741 | Shares | Defined | 2024-11-08 | |
| 2024-06-30 | $19,794,200 | 1,102,741 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $18,790,706 | 1,102,741 | Shares | Defined | 2024-05-03 | |
| No filing history on record for this holder in this stock. | ||||||